12-105223192-G-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_018171.5(APPL2):c.154-5467C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.377 in 152,012 control chromosomes in the GnomAD database, including 11,574 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.38   (  11574   hom.,  cov: 32) 
Consequence
 APPL2
NM_018171.5 intron
NM_018171.5 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.739  
Publications
4 publications found 
Genes affected
 APPL2  (HGNC:18242):  (adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2) The protein encoded by this gene is one of two effectors of the small GTPase RAB5A/Rab5, which are involved in a signal transduction pathway. Both effectors contain an N-terminal Bin/Amphiphysin/Rvs (BAR) domain, a central pleckstrin homology (PH) domain, and a C-terminal phosphotyrosine binding (PTB) domain, and they bind the Rab5 through the BAR domain. They are associated with endosomal membranes and can be translocated to the nucleus in response to the EGF stimulus. They interact with the NuRD/MeCP1 complex (nucleosome remodeling and deacetylase /methyl-CpG-binding protein 1 complex) and are required for efficient cell proliferation. A chromosomal aberration t(12;22)(q24.1;q13.3) involving this gene and the PSAP2 gene results in 22q13.3 deletion syndrome, also known as Phelan-McDermid syndrome. [provided by RefSeq, Oct 2011] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9). 
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.464  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.377  AC: 57260AN: 151894Hom.:  11584  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
57260
AN: 
151894
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.377  AC: 57256AN: 152012Hom.:  11574  Cov.: 32 AF XY:  0.380  AC XY: 28263AN XY: 74308 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
57256
AN: 
152012
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
28263
AN XY: 
74308
show subpopulations 
African (AFR) 
 AF: 
AC: 
9135
AN: 
41498
American (AMR) 
 AF: 
AC: 
6414
AN: 
15270
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1964
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
2238
AN: 
5132
South Asian (SAS) 
 AF: 
AC: 
2307
AN: 
4802
European-Finnish (FIN) 
 AF: 
AC: 
4570
AN: 
10582
Middle Eastern (MID) 
 AF: 
AC: 
157
AN: 
290
European-Non Finnish (NFE) 
 AF: 
AC: 
29317
AN: 
67950
Other (OTH) 
 AF: 
AC: 
882
AN: 
2104
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1778 
 3555 
 5333 
 7110 
 8888 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 556 
 1112 
 1668 
 2224 
 2780 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1303
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.